Cytophil, Inc. was founded in 2005 by Dr. William “Bill” Hubbard with the mission to design, develop, and manufacture innovative and cost-effective solutions for the vocal, orthopedic, dental, and aesthetic markets.
The foundation of Cytophil began in Dr. Hubbard’s basement in his hometown of East Troy, WI. Dr. Hubbard conducted research regarding synthetic ceramics that laid the groundwork for an entire class of biomaterials utilized in the world today.
Today, Cytophil has an established history of bringing products to market, holding multiple 510(k) and CE-mark product clearances, as well as supporting multiple contract partners from initial concept through regulatory clearance.
Commitment to Quality
Cytophil is ISO 13485:2016 & EN ISO 13485:2016 certified for the design, manufacture, and distribution on non-active implantable bone and soft tissue filler devices. Cytophil is authorized to perform contract design, manufacturing, and/or distribution of non-active implantable bone void filler devices, soft tissue filler devices, and single use delivery devices under this certification.
Cytophil utilizes its independently certified ISO Class 8 controlled environment to provide contamination control in all critical development and manufacturing processes.
Cytophil integrates each customer within our Quality Management System (QMS) to ensure seamless communication between production records, investigations, and change controls.